Literature DB >> 8919601

A primer on drug utilization review.

R T Kubacka1.   

Abstract

Many health care organizations evaluate drug utilization to improve the quality of patient care, reduce pharmaceutical expenditures, and enhance therapeutic outcomes. The Drug Regimen Review, instituted in 1974 as part of a quality assurance program for the care of Medicaid recipients, has reduced medication use, medication errors, adverse drug reactions, and drug-drug interactions. The Drug Usage Evaluation, a sophisticated analysis of drugs, their uses, and their contributions to various patient outcomes, is performed by member institutions of the Joint Commission on Accreditation of Healthcare Organizations. The 1990 Omnibus Budget Reconciliation Act (OBRA '90) established the Drug Utilization Review (DUR), which was implemented by state Medicaid outpatient prescription programs in 1993. Pharmacists performing DURs must review past patterns of drug misuse, monitor current therapy, and offer patient counseling. Drug utilization reviews have reduced inappropriate drug use and decreased drug costs.

Entities:  

Mesh:

Year:  1996        PMID: 8919601     DOI: 10.1016/s1086-5802(16)30049-3

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  3 in total

1.  Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?

Authors:  Maryam Mozaffar; Shahrzad Shahidi; Marjan Mansourian; Shirinsadat Badri
Journal:  J Transplant       Date:  2018-09-17

2.  Improving Quality of Service Among Antiretroviral Therapy Users Through Strategic Problem-Solving Approach at Bure Primary Hospital, Northwest Ethiopia.

Authors:  Yirga Yeshiwas; Ayal Debie; Nigusu Worku; Lake Yazachew
Journal:  Patient Prefer Adherence       Date:  2021-07-05       Impact factor: 2.711

3.  Evaluation of cotrimoxazole use as a preventive therapy among patients living with HIV/AIDS in Gondar University Referral Hospital, northwestern Ethiopia: a retrospective cross-sectional study.

Authors:  Begashaw Melaku Gebresillassie; Minaleshewa Biruk Gebeyehu; Tadesse Melaku Abegaz; Daniel Asfaw Erku; Abebe Basazn Mekuria; Yokabd Dechassa Tadesse
Journal:  HIV AIDS (Auckl)       Date:  2016-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.